{"id":145,"date":"2020-01-10T18:01:06","date_gmt":"2020-01-10T18:01:06","guid":{"rendered":"http:\/\/eprf.org\/?page_id=145"},"modified":"2020-01-15T15:29:22","modified_gmt":"2020-01-15T15:29:22","slug":"jeffrey-k-smith","status":"publish","type":"page","link":"https:\/\/eprf.net\/index.php\/jeffrey-k-smith\/","title":{"rendered":"Jeffrey K. Smith"},"content":{"rendered":"

\"\"\u00a0 \u00a0 1-732-302-9990<\/a>
\n<\/span>\"\"\u00a0 \u00a0 info@eprf.net<\/a><\/span><\/span><\/p>\n<\/div>

<\/div><\/div><\/div>

The Electrophysiology Research Foundation<\/u><\/span><\/strong> is a charitable organization incorporated on August 2, 1982. The Foundation is a non-profit corporation, organized and operated exclusively for charitable purposes.<\/span><\/p>\n<\/div>

<\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div><\/div><\/div>

\"\"\u00a0 \u00a0 1-732-302-9990<\/a>
\n<\/span>\"\"\u00a0 \u00a0 info@eprf.net<\/a><\/span><\/span><\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>

JEFF SMITH<\/strong><\/span><\/h2>\n<\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>

JEFF SMITH<\/span><\/strong><\/h2>\n<\/div>

\"\"Jeff Smith is Managing Director at the investment banking firm Berkery, Noyes & Co. LLC. He specializes in advising providers of software, information and services solutions to the global healthcare and life science industries. He is the former CEO and President of Lippincott Williams and Wilkins, the medical publisher headquartered in Philadelphia. Prior to Lippincott, Jeff was President of Kluwer Academic Publishers, the science publisher headquartered in the Netherlands. He is a graduate of Duke University and of the University of Wisconsin.<\/p>\n<\/div>

<\/div><\/div><\/div>

Reanalysis of the AFFIRM trial:<\/span><\/h3>\n<\/div>
<\/div>
<\/div><\/div>
<\/div>
<\/span><\/div>
Saksena S, Slee A, Waldo AL, Freemantle N, Reynolds M, Rosenberg Y, Rathod S, Grant S, Thomas E, Wyse DG: Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management): An Assessment of Individual Antiarrhythmic Drug Therapies Compared With Rate Control With Propensity Score-Matched Analyses. J Am Coll Cardiol 2011;58:1975\u201385<\/span><\/h5>\n
Click to Download \u00bb<\/a><\/h5>\n<\/div>
<\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-145","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/eprf.net\/index.php\/wp-json\/wp\/v2\/pages\/145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eprf.net\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/eprf.net\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/eprf.net\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/eprf.net\/index.php\/wp-json\/wp\/v2\/comments?post=145"}],"version-history":[{"count":5,"href":"https:\/\/eprf.net\/index.php\/wp-json\/wp\/v2\/pages\/145\/revisions"}],"predecessor-version":[{"id":304,"href":"https:\/\/eprf.net\/index.php\/wp-json\/wp\/v2\/pages\/145\/revisions\/304"}],"wp:attachment":[{"href":"https:\/\/eprf.net\/index.php\/wp-json\/wp\/v2\/media?parent=145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}